These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8875203)

  • 1. Diagnostic limits in precursor lesions of prostatic cancer.
    Algaba F; Trias I
    Eur Urol; 1996; 30(2):212-21. PubMed ID: 8875203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
    Helpap B; Riede C
    Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens.
    Qian J; Bostwick DG
    Pathol Res Pract; 1995 Sep; 191(9):860-7. PubMed ID: 8606866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma.
    Helpap B; Bonkhoff H; Cockett A; Montironi R; Troncoso P; Waters D; Bostwick D
    Pathologica; 1997 Jun; 89(3):288-300. PubMed ID: 9270265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia.
    Bostwick DG
    Cancer; 1996 Jul; 78(2):330-6. PubMed ID: 8674012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia for the development of prostate carcinoma. An update.
    Helpap BG; Bostwick DG; Montironi R
    Virchows Arch; 1995; 426(5):425-34. PubMed ID: 7543337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate.
    Helpap B
    Pathol Res Pract; 1995 Sep; 191(9):904-7. PubMed ID: 8606872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
    Rekhi B; Jaswal TS; Arora B
    Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancer.
    Meyer F; Têtu B; Bairati I; Lacombe L; Fradet Y
    Can J Urol; 2006 Oct; 13(5):3255-60. PubMed ID: 17076947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular evidence supporting the precursor nature of atypical adenomatous hyperplasia of the prostate.
    Cheng L; Montironi R; Davidson DD; Wang M; Lopez-Beltran A; Zhang S
    Mol Carcinog; 2019 Jul; 58(7):1272-1278. PubMed ID: 30920030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Working standards in prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia.
    Algaba F; Epstein JI; Fabus G; Helpap B; Nagle RB; Polito M
    Pathol Res Pract; 1995 Sep; 191(9):836-7. PubMed ID: 8606861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unifying hypothesis that links benign prostatic hyperplasia and prostatic intraepithelial neoplasia with prostate cancer. Invited comments.
    Harvey H
    Pathol Res Pract; 1995 Sep; 191(9):924-34. PubMed ID: 8606875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precursor lesions of prostate cancer.
    Chrisofos M; Papatsoris AG; Lazaris A; Deliveliotis C
    Crit Rev Clin Lab Sci; 2007; 44(3):243-70. PubMed ID: 17453919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precursor lesions to prostatic adenocarcinoma.
    Epstein JI
    Virchows Arch; 2009 Jan; 454(1):1-16. PubMed ID: 19048290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical adenomatous hyperplasia of the prostate: a critical review.
    Grignon DJ; Sakr WA
    Eur Urol; 1996; 30(2):206-11. PubMed ID: 8875202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens.
    Pacelli A; Bostwick DG
    Urology; 1997 Sep; 50(3):355-9. PubMed ID: 9301697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boundary in the pathologic evaluation of premalignant prostatic lesions.
    Algaba F
    Pathol Res Pract; 1995 Sep; 191(9):856-9. PubMed ID: 8606865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia.
    Sakr WA; Partin AW
    Urology; 2001 Apr; 57(4 Suppl 1):115-20. PubMed ID: 11295607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Premalignant and benign lesions in nodules of adenomatous hyperplasia].
    Miján Ortiz JL; Fernández Rodríguez A; Fernández Ruiz PL; de la Fuente Serrano A; Nogales Fernández F; Zuluaga Gómez A
    Arch Esp Urol; 1996 Sep; 49(7):684-7. PubMed ID: 9020004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
    Goel T; Garg S
    Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.